Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Mercaptamine 0.11% eye drops | Unlicensed |
|
|
Mercaptamine 0.55% eye drops | Unlicensed |
|
|
Mercaptamine capsules | NHSE commissioned. |
|
|
Mercaptopurine injection | For oncology |
|
 |
Mercaptopurine tablets | ESCA |
|
|
Meritene shake (powder) | Prescribed for liver patients at request of UHB liver/dietetic team only. Liver/hepatobiliary and pancreatic conditions. Supported by RICaD. |
|
|
Meropenem nebulised | Hospital only |
|
|
Mesalazine (Octasa®) | Octasa is preferred brand of choice |
|
|
Metaraminol injection | Hospital use only |
|
 |
Metformin M/R tablets | 2nd line - only for patients intolerant of slowly titrated standard release metformin. Sukkarto SR 500mg and 1000mg. |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
